Review



map kinase antibody, activated  (NSJ Bioreagents)


Bioz Verified Symbol NSJ Bioreagents is a verified supplier
Bioz Manufacturer Symbol NSJ Bioreagents manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    NSJ Bioreagents map kinase antibody, activated
    Map Kinase Antibody, Activated, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 96/100, based on 171 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/map+kinase+antibody%2C+activated/custom%40r30048%4040204967?v=NSJ+Bioreagents
    Average 96 stars, based on 171 article reviews
    map kinase antibody, activated - by Bioz Stars, 2026-08
    96/100 stars

    Images



    Similar Products

    96
    NSJ Bioreagents map kinase antibody, activated
    Map Kinase Antibody, Activated, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/map+kinase+antibody%2C+activated/custom%40r30048%4040204967?v=NSJ+Bioreagents
    Average 96 stars, based on 1 article reviews
    map kinase antibody, activated - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc anti p44 42 mitogen activated protein kinase
    Anti P44 42 Mitogen Activated Protein Kinase, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/map+kinase+antibody%2C+activated/pm40724843-212-4-19?v=Cell+Signaling+Technology+Inc
    Average 95 stars, based on 1 article reviews
    anti p44 42 mitogen activated protein kinase - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology p38 mitogen activated protein kinase mapk
    Alleviation of cynaropicrin-induced cytotoxicity through a <t>p38</t> <t>MAPK</t> inhibitor in Hep3B cells. (A) After treating cells with cynaropicrin for the indicated duration, changes in the expression of the three types of MAPKs were examined via Western blot analysis. (B-D) Cells were pretreated with the p38 MAPK inhibitor SB203580 for 1 h and then treated with cynaropicrin for 24 h. Thereafter, changes in morphology (B), cell viability (C), and expression of the indicated proteins (D) were examined. (C) Numerical data are presented as mean ± SD (n=3). *** p <0.001 compared to untreated group; ### p <0.001 compared to cynaropicrin-treated group.
    P38 Mitogen Activated Protein Kinase Mapk, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/map+kinase+antibody%2C+activated/pmc12059367-34-11-39?v=Santa+Cruz+Biotechnology
    Average 93 stars, based on 1 article reviews
    p38 mitogen activated protein kinase mapk - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc phospho p44 42 mitogen activated protein kinase mapk
    Alleviation of cynaropicrin-induced cytotoxicity through a <t>p38</t> <t>MAPK</t> inhibitor in Hep3B cells. (A) After treating cells with cynaropicrin for the indicated duration, changes in the expression of the three types of MAPKs were examined via Western blot analysis. (B-D) Cells were pretreated with the p38 MAPK inhibitor SB203580 for 1 h and then treated with cynaropicrin for 24 h. Thereafter, changes in morphology (B), cell viability (C), and expression of the indicated proteins (D) were examined. (C) Numerical data are presented as mean ± SD (n=3). *** p <0.001 compared to untreated group; ### p <0.001 compared to cynaropicrin-treated group.
    Phospho P44 42 Mitogen Activated Protein Kinase Mapk, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/map+kinase+antibody%2C+activated/pmc11348009-69-21-42?v=Cell+Signaling+Technology+Inc
    Average 95 stars, based on 1 article reviews
    phospho p44 42 mitogen activated protein kinase mapk - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc rabbit monoclonal anti p38 mitogen-activated protein (map) kinase
    Alleviation of cynaropicrin-induced cytotoxicity through a <t>p38</t> <t>MAPK</t> inhibitor in Hep3B cells. (A) After treating cells with cynaropicrin for the indicated duration, changes in the expression of the three types of MAPKs were examined via Western blot analysis. (B-D) Cells were pretreated with the p38 MAPK inhibitor SB203580 for 1 h and then treated with cynaropicrin for 24 h. Thereafter, changes in morphology (B), cell viability (C), and expression of the indicated proteins (D) were examined. (C) Numerical data are presented as mean ± SD (n=3). *** p <0.001 compared to untreated group; ### p <0.001 compared to cynaropicrin-treated group.
    Rabbit Monoclonal Anti P38 Mitogen Activated Protein (Map) Kinase, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/map+kinase+antibody%2C+activated/pm38999828-46-7-51?v=Cell+Signaling+Technology+Inc
    Average 96 stars, based on 1 article reviews
    rabbit monoclonal anti p38 mitogen-activated protein (map) kinase - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc anti phospho p44 42 mitogen activated protein kinase mapk
    Alleviation of cynaropicrin-induced cytotoxicity through a <t>p38</t> <t>MAPK</t> inhibitor in Hep3B cells. (A) After treating cells with cynaropicrin for the indicated duration, changes in the expression of the three types of MAPKs were examined via Western blot analysis. (B-D) Cells were pretreated with the p38 MAPK inhibitor SB203580 for 1 h and then treated with cynaropicrin for 24 h. Thereafter, changes in morphology (B), cell viability (C), and expression of the indicated proteins (D) were examined. (C) Numerical data are presented as mean ± SD (n=3). *** p <0.001 compared to untreated group; ### p <0.001 compared to cynaropicrin-treated group.
    Anti Phospho P44 42 Mitogen Activated Protein Kinase Mapk, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/map+kinase+antibody%2C+activated/pm38996930-90-74-81?v=Cell+Signaling+Technology+Inc
    Average 95 stars, based on 1 article reviews
    anti phospho p44 42 mitogen activated protein kinase mapk - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    Image Search Results


    Alleviation of cynaropicrin-induced cytotoxicity through a p38 MAPK inhibitor in Hep3B cells. (A) After treating cells with cynaropicrin for the indicated duration, changes in the expression of the three types of MAPKs were examined via Western blot analysis. (B-D) Cells were pretreated with the p38 MAPK inhibitor SB203580 for 1 h and then treated with cynaropicrin for 24 h. Thereafter, changes in morphology (B), cell viability (C), and expression of the indicated proteins (D) were examined. (C) Numerical data are presented as mean ± SD (n=3). *** p <0.001 compared to untreated group; ### p <0.001 compared to cynaropicrin-treated group.

    Journal: Biomolecules & Therapeutics

    Article Title: Cynaropicrin Induces Reactive Oxygen Species-Dependent Paraptosis-Like Cell Death in Human Liver Cancer Cells

    doi: 10.4062/biomolther.2025.011

    Figure Lengend Snippet: Alleviation of cynaropicrin-induced cytotoxicity through a p38 MAPK inhibitor in Hep3B cells. (A) After treating cells with cynaropicrin for the indicated duration, changes in the expression of the three types of MAPKs were examined via Western blot analysis. (B-D) Cells were pretreated with the p38 MAPK inhibitor SB203580 for 1 h and then treated with cynaropicrin for 24 h. Thereafter, changes in morphology (B), cell viability (C), and expression of the indicated proteins (D) were examined. (C) Numerical data are presented as mean ± SD (n=3). *** p <0.001 compared to untreated group; ### p <0.001 compared to cynaropicrin-treated group.

    Article Snippet: Antibodies against poly(ADP-ribose) polymerase (PARP), apoptosis-linked gene 2-interacting protein X (Alix), p38 mitogen activated protein kinase (MAPK), extracellular signal-regulated kinase ( de Ridder et al ., 2023 ), c-Jun N-terminal kinases (JNK), phosphor (p)-JNK, and β-actin were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA).

    Techniques: Expressing, Western Blot

    Effects of the p38 MAPK inhibitor on cynaropicrin-induced ER stress and mitochondrial impairment in Hep3B cells. The effects of SB203580 on the cynaropicrin-induced increase in intracellular Ca 2+ concentration (A, B), ER stress (C, D), and mitochondrial dysfunction (E, F) were evaluated via flow cytometry. (B, D, F) Numerical data are presented as mean ± SD (n=3). *** p <0.001 compared to untreated group; # p <0.05 and ### p <0.001 compared to cynaropicrin-treated group.

    Journal: Biomolecules & Therapeutics

    Article Title: Cynaropicrin Induces Reactive Oxygen Species-Dependent Paraptosis-Like Cell Death in Human Liver Cancer Cells

    doi: 10.4062/biomolther.2025.011

    Figure Lengend Snippet: Effects of the p38 MAPK inhibitor on cynaropicrin-induced ER stress and mitochondrial impairment in Hep3B cells. The effects of SB203580 on the cynaropicrin-induced increase in intracellular Ca 2+ concentration (A, B), ER stress (C, D), and mitochondrial dysfunction (E, F) were evaluated via flow cytometry. (B, D, F) Numerical data are presented as mean ± SD (n=3). *** p <0.001 compared to untreated group; # p <0.05 and ### p <0.001 compared to cynaropicrin-treated group.

    Article Snippet: Antibodies against poly(ADP-ribose) polymerase (PARP), apoptosis-linked gene 2-interacting protein X (Alix), p38 mitogen activated protein kinase (MAPK), extracellular signal-regulated kinase ( de Ridder et al ., 2023 ), c-Jun N-terminal kinases (JNK), phosphor (p)-JNK, and β-actin were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA).

    Techniques: Concentration Assay, Flow Cytometry

    A schematic diagram illustrating the mechanisms by which cynaropicrin induces cell death in Hep3B cells, including the promotion of mitochondrial ROS production, activation of the p38 MAPK pathway, inhibition of Alix protein, and enhancement of ER stress.

    Journal: Biomolecules & Therapeutics

    Article Title: Cynaropicrin Induces Reactive Oxygen Species-Dependent Paraptosis-Like Cell Death in Human Liver Cancer Cells

    doi: 10.4062/biomolther.2025.011

    Figure Lengend Snippet: A schematic diagram illustrating the mechanisms by which cynaropicrin induces cell death in Hep3B cells, including the promotion of mitochondrial ROS production, activation of the p38 MAPK pathway, inhibition of Alix protein, and enhancement of ER stress.

    Article Snippet: Antibodies against poly(ADP-ribose) polymerase (PARP), apoptosis-linked gene 2-interacting protein X (Alix), p38 mitogen activated protein kinase (MAPK), extracellular signal-regulated kinase ( de Ridder et al ., 2023 ), c-Jun N-terminal kinases (JNK), phosphor (p)-JNK, and β-actin were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA).

    Techniques: Activation Assay, Inhibition